York Bridge Wealth Partners, LLC Biogen Inc. Transaction History

York Bridge Wealth Partners, LLC

$394 Million
Q4 2022

A detailed history of York Bridge Wealth Partners, LLC transactions in Biogen Inc. stock. As of the latest transaction made, York Bridge Wealth Partners, LLC holds 1,027 shares of BIIB stock, worth $148,309. This represents 0.07% of its overall portfolio holdings.

Number of Shares

1,027

Previous 1,030 0.29%

Holding current value

$148,309

Previous $275,000 3.27%

% of portfolio

0.07%

Previous 0.07%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 26, 2023	SELL	$252.44 - $306.72 $757 - $920	-3 Reduced 0.29%	1,027 $0
Q2 2022 Jul 15, 2022	SELL	$187.54 - $223.02 $1,312 - $1,561	-7 Reduced 0.68%	1,030 $210,000
Q4 2021 Jan 19, 2022	SELL	$223.92 - $287.77 $671 - $863	-3 Reduced 0.29%	1,037 $249,000
Q3 2021 Oct 22, 2021	SELL	$282.99 - $369.05 $2,263 - $2,952	-8 Reduced 0.76%	1,040 $294,000
Q2 2021 Jul 22, 2021	SELL	$259.0 - $414.71 $1,295 - $2,073	-5 Reduced 0.47%	1,048 $363,000
Q1 2021 Apr 15, 2021	SELL	$242.95 - $284.63 $36,199 - $42,409	-149 Reduced 12.4%	1,053 $295,000
Q4 2020 Jan 19, 2021	SELL	$236.26 - $355.63 $14,884 - $22,404	-63 Reduced 4.98%	1,202 $294,000
Q3 2020 Oct 19, 2020	BUY	$264.77 - $305.71 $2,912 - $3,362	11 Added 0.88%	1,265 $359,000
Q2 2020 Jul 20, 2020	SELL	$258.66 - $342.55 $2,845 - $3,768	-11 Reduced 0.87%	1,254 $336,000
Q1 2020 Apr 16, 2020	SELL	$268.85 - $341.04 $137,920 - $174,953	-513 Reduced 28.85%	1,265 $400,000
Q4 2019 Jan 17, 2020	SELL	$220.06 - $304.07 $53,474 - $73,889	-243 Reduced 12.02%	1,778 $528,000
Q3 2019 Oct 21, 2019	SELL	$217.44 - $243.88 $20,874 - $23,412	-96 Reduced 4.53%	2,021 $471,000
Q2 2019 Jul 18, 2019	SELL	$219.29 - $241.72 $19,297 - $21,271	-88 Reduced 3.99%	2,117 $495,000
Q1 2019 May 09, 2019	SELL	$216.71 - $338.96 $9,968 - $15,592	-46 Reduced 2.04%	2,205 $521,000
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $58,206 - $73,724	-209 Reduced 8.5%	2,251 $677,000
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $25,241 - $33,009	-86 Reduced 3.38%	2,460 $867,000
Q2 2018 Aug 10, 2018	SELL	$257.52 - $306.91 $30,644 - $36,522	-119 Reduced 4.47%	2,546 $739,000
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $4,682 - $6,622	18 Added 0.68%	2,665 $713,000
Q4 2017 Feb 12, 2018	SELL	$307.64 - $344.58 $91,676 - $102,684	-298 Reduced 10.12%	2,647 $869,000
Q3 2017 Oct 27, 2017	SELL	$281.15 - $329.69 $14,057 - $16,484	-50 Reduced 1.67%	2,945 $922,000
Q2 2017 Aug 14, 2017	BUY	N/A	2,995	2,995 $816,000

Others Institutions Holding BIIB

# of Institutions

1,000

Shares Held

130M

Call Options Held

1.12M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.8B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of York Bridge Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on York Bridge Wealth Partners, LLC with notifications on news.

Account

York Bridge Wealth Partners, LLC Biogen Inc. Transaction History